Koneksa is a leading patient-centric digital biomarker company for the pharmaceutical and biotechnology industries that develops end-to-end solutions for remotely collected clinical data. Koneksa supports agile decision-making in drug development and market strategy. By delivering integrated solutions for efficient trial designs that produce more meaningful data, Koneksa aims to revolutionize effect detection in clinical research.
Koneksa launched in 2015 following incubation support and initial investment from the Merck Global Health Innovation Fund. The Koneksa Compare Software-as-a-Service (SaaS) platform is a single instance, multi-tenant environment deployed at more than 400 clinical research sites globally. Customers include more than a dozen pharmaceutical companies who subscribe to the platform and related scientific/technical services to enable clinical trials of new medicines that are assessed using our digital biomarkers. The company has a capital efficient history, with early funding from Waterline Ventures and in July 2020 completed a Series B led by Spring Mountain Capital that included McKesson Ventures, Novartis Pharma AG, MBX Capital, and participation from all existing investors. Koneksa has consistently achieved significant year-over-year revenue growth and is well funded to achieve profitability through organic growth.
We found no active remote jobs for Koneksa on Remotive.
> Browse 100s of live remote jobs!
Koneksa used to hire remotely:
Showing 1 archived remote job at Koneksa